The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson's disease

被引:55
|
作者
Pyszko, Joanna A. [1 ]
Strosznajder, Joanna B. [1 ]
机构
[1] Polish Acad Sci, Dept Cellular Signalling, Mossakowski Med Res Ctr, Warsaw, Poland
关键词
sphingosine kinases; dopaminergic neurons; apoptosis; PD model; NEUROBLASTOMA SH-SY5Y CELLS; ALPHA-SYNUCLEIN; SPHINGOSINE-1-PHOSPHATE RECEPTORS; SPHINGOLIPID METABOLISM; DOPAMINERGIC-NEURONS; GENE-EXPRESSION; LIPID RAFTS; 1-PHOSPHATE; CERAMIDE; APOPTOSIS;
D O I
10.5114/fn.2014.45567
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sphingosine kinases (Sphk1/2 EC 2.7.1.91) are responsible for synthesis of sphingosine-1-phosphate (S1P) and for regulation of the bioactive sphingolipids homeostasis. Sphingosine-1-phosphate can act as a potent messenger in an autocrine/paracrine manner through five specific G protein-coupled receptors (GPCR) S1P1-5. This sphingolipid is involved in the mechanism of transcription, mitochondrial function, neuronal viability and degeneration. Until now the involvement of Sphk1/2 and sphingolipid alterations in Parkinson's disease (PD) remains unknown. Recent studies have indicated the role of sphingolipids in the regulation of alpha-synuclein (ASN) in the PD brain. Our latest data demonstrated significant inhibition of Sphk1 gene expression and activity in an in vitro PD model, induced by 1-methyl-4-phenylpyridinium (MPP+). The aim of this study was to investigate the role of Sphks inhibition in ASN secretion and in the molecular mechanism of neuronal death in the PD model. Our study was carried out using neuronal dopaminergic SH-SY5Y control cells, transfected with the human gene for ASN or with an empty vector These cells were treated with MPP+ (1-3 mM), which represents an experimental PD model, or with the Sphks inhibitor (1-5 mu M SKI II) for 3-24 h. Our data indicated that MPP+ (3 mM) induced significant alterations of Sphks and S1P lyase (SPL) gene expression. Reduced activity of Sphk1 and Sphk2 in the cytosolic fraction and in the crude nuclear fraction, respectively, was observed. Sphks inhibition evoked enhancement of ASN secretion, suppression of PI3K/Akt phosphorylation and activation of gene expression for the pro-apoptotic Bcl-2 proteins Bax and BH3-only protein Harakiri. Moreover, a lower level of cytochrome c in the mitochondrial fraction and caspase-dependent degradation of DNA-bound enzyme poly(ADP-ribose) polymerase (PARP-1) were observed. The caspase inhibitor (20 mu M Z-VAD-FMK) significantly enhanced neuronal cell viability in MPP+ oxidative stress. However, exogenous S1P (1 mu M) exerted a more efficient neuroprotective effect as compared to Z-VAD-FMK. In summary, these data indicated that Sphk1 inhibition plays an important role in caspase-dependent apoptotic neuronal death in an experimental PD model.
引用
收藏
页码:260 / 269
页数:10
相关论文
共 50 条
  • [31] Regulatory mechanism of FTO in Parkinson's disease cell model
    Chen, Yulu
    Chen, Yake
    Song, Yu
    FASEB JOURNAL, 2021, 35
  • [32] A cell protective mechanism in a murine model of Parkinson's disease
    Öztas¸, Emin
    Topal, Turgut
    Turkish Journal of Medical Sciences, 2003, 33 (05) : 295 - 299
  • [33] Molecular landscape of Parkinson's disease reveals a key role for lipids and lipoproteins
    Klemann, C. J. H. M.
    Martens, G. J. M.
    Sharma, M.
    Martens, M. B.
    Isacson, O.
    Gasser, T.
    Visser, J. E.
    Poelmans, G.
    MOVEMENT DISORDERS, 2016, 31 : S280 - S280
  • [34] Dopamine-induced, genotoxic activation of programmed cell death - A role in nigrostriatal neuronal degeneration in Parkinson's disease?
    Ziv, I
    Barzilai, A
    Offen, D
    Stein, R
    Achiron, A
    Melamed, E
    PARKINSON'S DISEASE, 1996, 69 : 229 - 233
  • [35] Protective mechanism of Syringic acid in an experimental model of Parkinson's disease
    Guzelad, Ozge
    Ozkan, Ayse
    Parlak, Hande
    Sinen, Osman
    Afsar, Ebru
    Ogut, Eren
    Yildirim, Fatos Belgin
    Bulbul, Mehmet
    Agar, Aysel
    Aslan, Mutay
    METABOLIC BRAIN DISEASE, 2021, 36 (05) : 1003 - 1014
  • [36] Protective mechanism of Syringic acid in an experimental model of Parkinson’s disease
    Özge Güzelad
    Ayşe Özkan
    Hande Parlak
    Osman Sinen
    Ebru Afşar
    Eren Öğüt
    Fatoş Belgin Yıldırım
    Mehmet Bülbül
    Aysel Ağar
    Mutay Aslan
    Metabolic Brain Disease, 2021, 36 : 1003 - 1014
  • [37] The role and molecular mechanism of α synuclein in Parkinson's disease: A diagnostic model for corneal nerve fiber injury☆
    Guan, Chenyang
    Xu, Xiaozhou
    Yin, Peixiao
    Niu, Xuebin
    Cui, Guiyun
    Xiao, Lishun
    Zan, Kun
    Xu, Chuanying
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 306
  • [38] Molecular mechanism for induction of neuronal death by beta amyloid protein in Alzheimer's disease
    Subhani, Farhan U.
    BRAIN PATHOLOGY, 2006, 16 : S121 - S121
  • [39] Molecular mechanism for induction of neuronal death by beta amyloid protein in Alzheimer's disease
    Hail Subhani, Farhan Ul
    ANNALS OF NEUROLOGY, 2006, 60 : S9 - S9
  • [40] Molecular mechanisms of programmed cell death in dopaminergic neurodegeneration of Parkinson's disease
    Vila, Miquel
    REVISTA DE NEUROLOGIA, 2010, 50 : S1 - S3